Pelletier, R.; Gicquel, T.; Simoes Eugenio, M.; Ferron, P.-J.; Morel, I.; Delehouzé, C.; Dimanche-Boitrel, M.-T.; Rousselot, M.; Le Daré, B.
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics 2022, 14, 2665.
https://doi.org/10.3390/pharmaceutics14122665
AMA Style
Pelletier R, Gicquel T, Simoes Eugenio M, Ferron P-J, Morel I, Delehouzé C, Dimanche-Boitrel M-T, Rousselot M, Le Daré B.
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics. 2022; 14(12):2665.
https://doi.org/10.3390/pharmaceutics14122665
Chicago/Turabian Style
Pelletier, Romain, Thomas Gicquel, Mélanie Simoes Eugenio, Pierre-Jean Ferron, Isabelle Morel, Claire Delehouzé, Marie-Thérèse Dimanche-Boitrel, Morgane Rousselot, and Brendan Le Daré.
2022. "A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline" Pharmaceutics 14, no. 12: 2665.
https://doi.org/10.3390/pharmaceutics14122665
APA Style
Pelletier, R., Gicquel, T., Simoes Eugenio, M., Ferron, P.-J., Morel, I., Delehouzé, C., Dimanche-Boitrel, M.-T., Rousselot, M., & Le Daré, B.
(2022). A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics, 14(12), 2665.
https://doi.org/10.3390/pharmaceutics14122665
